| Akt2 | ACT Serine/Threonine Kinase 2 |
| ALA | α-linolenic acid |
| Bc1 | complex III or ubiquinol cytochrome C oxidoreductase or cytochrome bc1 |
| Bcl-2 | B-cell CLL/lymphoma 2 |
| CDK4 | cyclin-dependent kinase 4 |
| CF | cystic fibrosis |
| CGA | chlorogenic acid |
| COX-2 | cyclooxygenase 2 |
| CRP | C-reactive protein |
| CVD | cardiovascular disease |
| Cyclo C | cytochrome C |
| DHA | docosahexaenoic acid |
| DSS | dextran sodium sulfate |
| EGFR | epidermal growth factor receptor |
| EL | enterolactone |
| EPA | eicosapentaenoic acid |
| HER2(+) | HER2-positive breast cancer |
| Hs-CRP | highly sensitive C-reactive protein |
| HYA | 10-hydroxy-cis-12-octadecenoic acid |
| IGF-I | insulin like growth factor 1 |
| IGFIR | insulin like growth factor 1 receptor |
| IKKβ | IκB Kinase β |
| IL-1β | interleukin 1β |
| IL-6 | interleukin 6 |
| IL-10 | interleukin 10 |
| LOB3 | [1–9-N α C]-linusorb B3 |
| MAPK | mitogen-activated protein kinases |
| MAT | matairesinol |
| NF-κB | the nuclear factor kappa B |
| PGE2 | prostaglandin E2 |
| PI3k-Akt | the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) |
| SDG | diglucoside secoisolaresinol |
| SRC | proto-oncogene tyrosine-protein kinase Sr |
| STAT3 | signal transducers and activators of transcription 3 |
| sVCAM-1 | circulating vascular cell adhesion molecule-1 |
| TNF-α | tumor necrosis factor α |
| TRAS | trastuzumab |